期刊文献+

A robust reporting system for measurement of SARS-CoV-2 spike fusion efficiency

原文传递
导出
摘要 Dear Editor,During the COVID-19 pandemic,several SARS-CoV-2 variants such as Alpha,Delta,and Omicron successively became dominant worldwide.The infection of SARS-CoV-2 is triggered by the binding of spike protein to the cell-surface receptor angiotensinconverting enzyme 2(ACE2),which then fuses with cell membrane or lysosomal membrane after endocytosis.1 Extensive cell fusion and syncytia formation are a signature feature of severe SARS-CoV-2 and may play an important role in COVID-19 pathogenesis.Research has shown that SARS-CoV-2 spikemediated cell fusion leads to the formation of abnormal and multinucleated cells in the lungs of patients.2 Accordingly,the fusion ability of SARS-CoV-2 spike protein may be a leading indicator of viral infectivity and disease severity in SARS-CoV-2 patients.
出处 《Signal Transduction and Targeted Therapy》 SCIE CSCD 2022年第7期2141-2143,共3页 信号转导与靶向治疗(英文)
基金 financially supported by the National Key R&D Project of China 2018YFA0902300 the National Natural Science Foundation of China 81830101 the Biological Safety Project 19SWAQ08 the Medical Innovation Project 17SAZ13 and Beijing Nova Program Z171100001117119.
  • 相关文献

参考文献1

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部